IMUX

Immunic Stock Price

14.03
1.12 (8.68%)
Upgrade to Real-Time
Regular Market
14.03

Low
7.50

52 Week Range

High
28.2138

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.12 8.68% 14.03 14:13:53
Open Price Low Price High Price Close Price Prev Close
12.90 12.77 14.08 12.91
Bid Price Ask Price Spread News
13.92 14.03 0.11 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
889 82,246 $ 13.46 $ 1,107,325 224,435 7.50 - 28.2138
Last Trade Time Type Quantity Stock Price Currency
14:13:49 86 $ 14.03 USD

Immunic Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 290.68M 20.72M 13.81M $ - $ - -7.99 -5.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Immunic News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IMUX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.4115.649912.5114.12201,496-0.38-2.64%
1 Month15.7416.9912.5114.71157,115-1.71-10.86%
3 Months17.0228.213812.5117.11243,910-2.99-17.57%
6 Months18.1028.213812.5117.33245,494-4.07-22.49%
1 Year7.7928.21387.5016.23373,4786.2480.1%
3 Years22.0028.21384.1915.67220,977-7.97-36.23%
5 Years22.0028.21384.1915.67220,977-7.97-36.23%

Immunic Description

Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORyt and IMU-856 targets the restoration of the intestinal barrier function.


Your Recent History
NASDAQ
IMUX
Immunic
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.